ALLI is a Oral Capsule in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Orlistat.
| Product ID | 0135-0461_1ddf30ff-74b5-415a-92d1-1f4a5152a1e6 |
| NDC | 0135-0461 |
| Product Type | Human Otc Drug |
| Proprietary Name | ALLI |
| Generic Name | Orlistat |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2007-02-07 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021887 |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Substance Name | ORLISTAT |
| Active Ingredient Strength | 60 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2016-09-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021887 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-02-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021887 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-02-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021887 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-02-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021887 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-02-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021887 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-09-01 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021887 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-02-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021887 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-02-07 |
| Marketing End Date | 2014-01-21 |
| Marketing Category | NDA |
| Application Number | NDA021887 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2007-02-07 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| ORLISTAT | 60 mg/1 |
| SPL SET ID: | a2d3bd73-f3af-4ea5-a57c-66b0004cfe4f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0135-0461 | ALLI | orlistat |
| 61269-565 | ORLISTAT | orlistat |
| 0004-0257 | Xenical | orlistat |
| 61269-460 | Xenical | orlistat |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ALLI 97205516 not registered Live/Pending |
Lifegrowth Psychological Services, Inc. 2022-01-06 |
![]() ALLI 90726602 not registered Live/Pending |
PMG Worldwide, LLC 2021-05-21 |
![]() ALLI 90069453 not registered Live/Pending |
ALLI SOLUTIONS LLC 2020-07-23 |
![]() ALLI 86120511 not registered Dead/Abandoned |
GLAXOSMITHKLINE CONSUMER HEALTHCARE (US) IP LLC 2013-11-15 |
![]() ALLI 85748568 not registered Dead/Abandoned |
ALLIANCE WORKFORCE SOLUTIONS, LLC 2012-10-08 |
![]() ALLI 85167773 not registered Dead/Abandoned |
GlaxoSmithKline LLC 2010-11-03 |
![]() ALLI 85040057 not registered Dead/Abandoned |
GlaxoSmithKline LLC 2010-05-17 |
![]() ALLI 78859797 3270351 Live/Registered |
GLAXOSMITHKLINE CONSUMER HEALTHCARE (US) 2006-04-12 |
![]() ALLI 78786441 3270150 Live/Registered |
GLAXOSMITHKLINE CONSUMER HEALTHCARE (US) 2006-01-06 |
![]() ALLI 78699273 3357341 Live/Registered |
GLAXOSMITHKLINE CONSUMER HEALTHCARE (US) IP LLC 2005-08-24 |
![]() ALLI 78421527 not registered Dead/Abandoned |
SmithKline Beecham Corporation 2004-05-19 |
![]() ALLI 78023795 not registered Dead/Abandoned |
Verbatim Corporation 2000-08-30 |